Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Synthetic Protein Company Gains $25M in New Funds

E. coli

A company designing engineered proteins to work better than natural chemistries as treatments for disease is raising $25 million in its first venture round. . . . → Read More: Synthetic Protein Company Gains $25M in New Funds

Infographic – Record Q3 Global Health Investments

Health care investments Q3 2021

Venture investment volumes in health care and life science start-up companies hit record levels so far in 2021, already surpassing levels for all of 2020. . . . → Read More: Infographic – Record Q3 Global Health Investments

Infographic – Q3 2021 Venture Funds Continue Banner Year

Q3 2021 venture funds

Venture investors worldwide continue to look past the pandemic as investments in start-up enterprises rose to new levels in the U.S., Asia, and elsewhere. . . . → Read More: Infographic – Q3 2021 Venture Funds Continue Banner Year

AI-Designed Antibodies for Start-Up Sought in Open Call

Computational biology illustration

An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company. . . . → Read More: AI-Designed Antibodies for Start-Up Sought in Open Call

European Life Science Venture Fund Raises €472M

Euro investments

A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe. . . . → Read More: European Life Science Venture Fund Raises €472M

Crispr Licensed for Eye Disease Gene Therapies

Retinal gene therapy

A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies

Infographic – Cruising Biotech Index Takes Late Dip

Nasdaq Biotech Index, 3rd qtr 2021

NBI, an indicator of investor sentiment in the industry, continued its choppy climb through most of the third quarter, only to start another decline in late September. . . . → Read More: Infographic – Cruising Biotech Index Takes Late Dip

Precision Neuroscience Company Starts-Up, Raises $500M

Brain activity graphic

A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M

Seed Stage Investors Raise $450M for New Fund

Stock market graphic

A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund. . . . → Read More: Seed Stage Investors Raise $450M for New Fund

Synthetic Antibody Company Goes Public in $230M Merger

Four fist bump

A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger. . . . → Read More: Synthetic Antibody Company Goes Public in $230M Merger